AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « lung »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
lumbar < lung < lungen  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000001 (2020) A. Prasse [Allemagne] ; F. Bonella [Allemagne] ; U. Müller-Ladner [Allemagne] ; T. Witte [Allemagne] ; N. Hunzelmann [Allemagne] ; J. Distler [Allemagne][Treatment of systemic sclerosis-associated interstitial lung disease].
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000027 (2020) Shanshan Deng [États-Unis, République populaire de Chine] ; Michael J. Clowers [États-Unis] ; Walter V. Velasco [États-Unis] ; Marco Ramos-Castaneda [États-Unis] ; Seyed Javad Moghaddam [États-Unis]Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
000036 (2020) B P Hibler [États-Unis] ; A. Markova [États-Unis]Treatment of severe cutaneous adverse reaction with tocilizumab.
000070 (2020) Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000087 (2020) Wanhai Ke ; Li Zhang ; Yan DaiThe role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000103 (2020) Champa N. Ratnatunga [Australie] ; Viviana P. Lutzky [Australie] ; Andreas Kupz [Australie] ; Denise L. Doolan [Australie] ; David W. Reid [Australie] ; Matthew Field [Australie] ; Scott C. Bell [Australie] ; Rachel M. Thomson [Australie] ; John J. Miles [Australie]The Rise of Non-Tuberculosis Mycobacterial Lung Disease
000105 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000125 (2020) Gali Epstein Shochet [Israël] ; Elizabetha Brook [Israël] ; Becky Bardenstein-Wald [Israël] ; David Shitrit [Israël]TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
000164 (2020) Giulia Cassone ; Andreina Manfredi ; Fabiola Atzeni ; Vincenzo Venerito ; Caterina Vacchi ; Valentina Picerno ; Federica Furini ; Gian Luca Erre ; Paola Tomietto ; Anna Laura Fedele [Italie] ; Giovanni Della Casa [Italie] ; Valeria Nucera ; Chiara Giannitti [Italie] ; Carlo Salvarani ; Marco SebastianiSafety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
000173 (2020) Siddappa N. Byrareddy [États-Unis] ; Mahesh Mohan [États-Unis]SARS-CoV2 induced respiratory distress: Can Cannabinoids be added to anti-viral therapies to reduce lung inflammation?
000210 (2020) Thomas Koudstaal ; Karin A. Boomars ; Mirjam KoolPulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
000213 (2020) Ludivine Renaud [États-Unis] ; Willian A. Da Silveira [Royaume-Uni] ; Naoko Takamura [États-Unis] ; Gary Hardiman [États-Unis, Royaume-Uni] ; Carol Feghali-Bostwick [États-Unis]Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
000214 (2020) Alyson W. Wong [Canada] ; Christopher J. Ryerson [Canada] ; Sabina A. Guler [Suisse]Progression of fibrosing interstitial lung disease
000233 (2020) Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000257 (2020) Stefanie Glaubitz ; Rachel Zeng ; Jens SchmidtNew insights into the treatment of myositis
000276 (2020) Giacomo Bellani [Italie] ; Tài Pham [France] ; John G. Laffey [Irlande (pays)]Missed or delayed diagnosis of ARDS: a common and serious problem
000286 (2020) Tiago Torres [Portugal] ; Luis Puig [Espagne]Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "lung" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "lung" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    lung
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021